PetMed incurred a loss of $0.03 per share in the third quarter, and a loss of $0.1 per share in the same period last year

On February 11th, PetMed reported a loss of $0.03 per share in the third quarter, compared to a loss of $0.10 per share in the same period last year; Sales revenue of 53 million US dollars; Net loss of $707000, a year-on-year decrease of 65%; Adjusted EBITDA of $2 million.